Your browser doesn't support javascript.
loading
Phage-assisted evolution of botulinum neurotoxin proteases with reprogrammed specificity.
Blum, Travis R; Liu, Hao; Packer, Michael S; Xiong, Xiaozhe; Lee, Pyung-Gang; Zhang, Sicai; Richter, Michelle; Minasov, George; Satchell, Karla J F; Dong, Min; Liu, David R.
Affiliation
  • Blum TR; Merkin Institute of Transformative Technologies in Healthcare, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.
  • Liu H; Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA 02138, USA.
  • Packer MS; Howard Hughes Medical Institute, Harvard University, Cambridge, MA 02138, USA.
  • Xiong X; Department of Urology, Boston Children's Hospital, Boston, MA 02115, USA.
  • Lee PG; Department of Microbiology and Department of Surgery, Harvard Medical School, Boston, MA 02115, USA.
  • Zhang S; Merkin Institute of Transformative Technologies in Healthcare, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.
  • Richter M; Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA 02138, USA.
  • Minasov G; Howard Hughes Medical Institute, Harvard University, Cambridge, MA 02138, USA.
  • Satchell KJF; Department of Urology, Boston Children's Hospital, Boston, MA 02115, USA.
  • Dong M; Department of Microbiology and Department of Surgery, Harvard Medical School, Boston, MA 02115, USA.
  • Liu DR; Department of Urology, Boston Children's Hospital, Boston, MA 02115, USA.
Science ; 371(6531): 803-810, 2021 02 19.
Article de En | MEDLINE | ID: mdl-33602850
ABSTRACT
Although bespoke, sequence-specific proteases have the potential to advance biotechnology and medicine, generation of proteases with tailor-made cleavage specificities remains a major challenge. We developed a phage-assisted protease evolution system with simultaneous positive and negative selection and applied it to three botulinum neurotoxin (BoNT) light-chain proteases. We evolved BoNT/X protease into separate variants that preferentially cleave vesicle-associated membrane protein 4 (VAMP4) and Ykt6, evolved BoNT/F protease to selectively cleave the non-native substrate VAMP7, and evolved BoNT/E protease to cleave phosphatase and tensin homolog (PTEN) but not any natural BoNT protease substrate in neurons. The evolved proteases display large changes in specificity (218- to >11,000,000-fold) and can retain their ability to form holotoxins that self-deliver into primary neurons. These findings establish a versatile platform for reprogramming proteases to selectively cleave new targets of therapeutic interest.
Sujet(s)

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Toxines botuliniques / Ingénierie des protéines / Évolution moléculaire dirigée Limites: Animals / Humans Langue: En Journal: Science Année: 2021 Type de document: Article Pays d'affiliation: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Toxines botuliniques / Ingénierie des protéines / Évolution moléculaire dirigée Limites: Animals / Humans Langue: En Journal: Science Année: 2021 Type de document: Article Pays d'affiliation: États-Unis d'Amérique
...